PDCI has developed considerable expertise assisting manufacturers with product listing agreements(PLAs) through the pan-Canadian Pharmaceutical Alliance (pCPA), with individual provinces (including Quebec) and with private payers. With the formalization of the pCPA process and private payers moving aggressively into the PLA environment (see PDCIs white paper), PDCI is growing ... Read More
News & Events
25
Nov2015
13
Nov2015
PMPRB wins at Federal Court of Appeal – Maintains jurisdiction over patented generic products
/ News, PMPRB, What's New
2015 FCA 249 Attorney General of Canada v Sandoz (A-302-14) & v ratiopharm (now Teva) (A-303-14).
The central issue in both appeals is whether the Federal Court judge properly held that Sandoz and ratiopharm (collectively the respondents) fell outside of the jurisdiction of the Board as they were not “patentees” within ... Read More
03
Nov2015
Presentation and Poll Results from PDCI Market Access Product Listing Agreement (PLA) Webinar is Now Available
/ pCPA, What's New
On Friday, October 30, 2015 PDCI presented a webinar entitled “Market Access Climate Change: the Evolving Impact of Product Listing Agreements”.
The purpose of this webinar was to:
Shed light on the recent developments at the pCPA; and
Enhance the understanding of the growing practice of PLA negotiations in the private payer ... Read More
26
Oct2015
CADTH: Extending Deadline on Consultation on Procedures for the CADTH Common Drug Review
/ CADTH, News, What's New
As requested by stakeholders, the deadline for the following CADTH calls for stakeholder input has been extended to November 9, 2015 at 5:00 p.m. EST:
CDR Update – Issue 111
CADTH Consultation: Revisions to the Common Drug Review Procedure
Invites stakeholder comments and feedback on the following proposed revisions to the Procedure ... Read More
26
Oct2015
CAHR National Day: National Approaches to Pharma Policy: International & Canadian Perspectives
/ CAHR, News, What's New
The Canadian Association for Healthcare Reimbursement (CAHR) is hosting a one-day event to discuss two key issues of relevance to the pharmaceutical and life sciences sectors following the October 2015 federal election. Maclean’s magazine’s and event moderator, Paul Wells, will be present to share his knowledge on innovation policy and ... Read More
20
Oct2015
PDCI Market Access WEBINAR ‒ Market Access Climate Change: the Evolving Impact of Product Listing Agreements
/ News, pCPA, Upcoming Events
Interested in learning more about new developments at the pan-Canadian Pharmaceutical Alliance (pCPA)?
Curious to know more about private payer Product Listing Agreements (PLAs) in Canada?
PDCI Market Access (PDCI) is hosting a free webinar on Friday, October 30, 2015 from 11:00 AM -12:00 PM EDT titled Market Access Climate Change: the ... Read More
16
Oct2015
INESSS is offering an opportunity for in-person meetings to manufacturers who have filed a submission by the deadline for drugs to be listed on the June 2016 “Liste des médicaments”. These meetings will be held between December 7 and December 18, 2015, inclusive.
Meetings will cover the following:
Discussion on clinical studies
Discussion ... Read More
16
Oct2015
In a recent update released on their website, the pan-Canadian Pharmaceutical Alliance (pCPA) announced two significant developments:
Québec is now participating in the pCPA; and
The Office of the pCPA (the Office) is now operational.
In Fall 2014, the Provincial/Territorial Health Ministers announced intentions for Québec’s participation in the Federation’s Health Care ... Read More
06
Oct2015
Based on stakeholder feedback received in May 2015, CADTH has announced that in the limited instances where no Canadian patient group exists, individual patient and caregiver input will now be accepted for the CADTH Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) programs, effective immediately.
Please note that for ... Read More
31
Jul2015
Topics covered in the NEWSletter include:
Soliris Pre-Hearing Conference
New Staff Member – Legal Services
Update: Compendium of Policies, Guidelines and Procedures
Part C – Guidelines and Procedures
Schedule 9 – CPI-Adjustment Methodology
Schedule 2 – Comparable Dosage Forms
2016 HDAP Meeting Schedule & Filing Requirements:
February 29
May 2
September 12
November 28
PMPRB Transition to Canada.ca
Update: Germany Recognized Price Source
Summary ... Read More